DILG Compliance with Sec. 93 (Transparency Seal) R.A. No. 10352 (General Appropriations Act FY 2013)
I. The agency's mandate and functions, names of its officials with their positions and designation, and contact information
a. Powers and Functions
b. Vision, Mission and Goals
c. Key Officials
II. Annual Report
a. Statement of Allotment, Obligation and Balances
b. Disbursement and Income
- QMS Fund Utilization Monitoring Reports
- Appropriation, Obligations And Disbursements as of 2019
- List of Allotments and Sub-Allotments
- Statement of Appropirations, Allotments, Obligations, Disbursements & Balances
- Aging of Due and Demandable Obligation
- Summary of Appropriations, Allotments, Obligations, Disbursements & Balances by Object of Expenditure
- Status of Funds
- Statement of Cash Flow as of 2021
- Statement of Cash Flow as of 2020
- Statement of Cash Flow as of 2019
- Statement of Cash Flow for All Funds as of (2018)
- Statement of Cash Flow for 2016
- Statement of Cash Flow as of December 31, 2015
- Statement of Cash Flow for 2014
- Statement of Cash Flow as of (2013)
- Detailed Balance Sheet as of (2013)
- Detailed Statement of Income and Statement as of October 2013
- Detailed Statement of Income and Expenses (as of 3rd Quarter 2013)
- Consolidated Worksheet for the month ended as of (2018)
- Consolidated Post-Closing Trial Balance as of December 31, 2020
- Post-Closing Trial Balance as of December 31, 2020 (Fund 101 and Fund 102)
- Consolidated Post-Closing Trial Balance as of December 31, 2018
- Consolidated Trial Balance as of December 31, 2018
- Post-Closing Trial Balance as of December 31, 2018 (Fund 101 and Fund 102)
- Consolidated Trial Balance as of September 30, 2018
- Trial Balance as of (2018)
- Consolidated Trial Balance as of June 30, 2021
- Consolidated Trial Balance for the Quarter Ended December 31, 2020
- Consolidated Trial Balance for the Quarter Ended September 30, 2020
- Consolidated Trial Balance for the Quarter Ended June 30, 2020
- Consolidated Trial Balance for the Quarter Ended June 30, 2018
- Consolidated Trial Balance for the Quarter Ended March 31, 2018
- Trial Balance for 2021
- Trial Balance for 2020
- Trial Balance for 2019
- Trial Balance for 2017
- Trial Balance for 2016
- Trial Balance for 2015
- Trial Balance for 2014
- Trial Balance as of October 2013
- Consolidated Worksheet for the Quarter Ended June 30, 2018
- Worksheet as of (2021)
- Consolidated Worksheet for the Month Ended June 30, 2021
- Worksheet as of (2020)
- Worksheet as of (2018)
- Consolidated Worksheet for the Quarter Ended March 31, 2018
- Worksheet as of March 31, 2018 (F101 and F102)
- Monthly Disbursement Report for FY 2021
- Monthly Disbursement Report for FY 2020
- Monthly Disbursement Report for FY 2019
- Monthly Disbursement Report for FY 2018
- Monthly Disbursement Report for FY 2017
- Monthly Disbursement Report for FY 2016
- Monthly Disbursement Report for FY 2015
- Monthly Disbursement Report for FY 2014
- Monthly Disbursement Report for FY 2013
- Monthly Disbursement Report FY 2012
- Schedule of Advances to Officers and Employees for 2021
- Schedule of Advances to Officers and Employees for 2020
- Schedule of Advances to Officers and Employees for 2019
- Schedule of Advances to Officers and Employees for 2018
- Schedule of Advances to Officers and Employees for 2017
- Schedule of Advances to Officers and Employees for 2016
- Schedule of Advances to Officers and Employees for 2015
- Schedule of Advances to Officers and Employees for 2014
- Schedule of Advances to Officers and Employees for 2013
- Schedule of Advances to Officers and Employees (as of October 2012)
- Statement of Financial Performance
- Statement of Financial Position
- Statement of Changes in Net Assets/Equity All Funds
- Statement of Consolidated Detailed Financial Performance as of December 31, 2018
- Statement of Consolidated Detailed Financial Position as of December 31, 2018
- Statement of Consolidated Condensed Statement of Financial Performance For the Quarter Ending December 31, 2018
- Statement of Consolidated Condensed Statement of Financial Position as of December 31, 2018
- Statement of Condensed Financial Performance for the Quarter Ending December 2018 (Fund 101 and Fund 102)
- Statement of Condensed Financial Position as of December 31, 2018 (Fund 101 and Fund 102)
- Statement of Detailed Financial Performance for the Quarter Ending December 31, 2018 (Fund 101 and Fund 102)
- Statement of Detailed Financial Position as of December 31, 2018 (Fund 101 and Fund 102)
- Statement of Condensed Financial Performance for the Quarter Ending December 2015 Consolidated (Fund 101 and Fund 102)
- Statement of Detailed Financial Performance for the Quarter Ending December 2015 Consolidated (Fund 101 and Fund 102)
- Statement of Detailed Financial Performance for the Quarter Ending December 2015 Consolidated (Fund 101 and Fund 102)
- Statement of Financial Position as of December 2015
- Quarterly Report of Revenue and other Receipts
- Report Payment of CNA for FY 2016
d. Financial Plan
e. Monthly Cash Program
III. DILG approved budgets and corresponding targets
a. Approved Budgets
b. Corresponding Targets
IV. Major programs and projects categorized in accordance with the five key results areas under E.O. No. 43, s. 2011
V. The program/project beneficiaries as identified in the applicable special provisions
VI. Status of implementation and program/project evaluation and/or assessment reports
VII. Annual Procurement Plan (APP)
VIII. Contracts awarded and the name of contractors/suppliers/consultants
IX. Operational Planning and Budgeting
X. Accomplishment Report
ARTA (Compliance to Citizen's Charter)
QMS Management Review Minutes (November 5, 2019)
DILG R-3 List of SALN Compliant
Transmittal for SPMS
DILG R0-3 Quality Policy
DILG R0-3 Quality Manual
DILG R0-3 System Procedure Manual
DILG R0-3 Operating Procedure Manuals
DILG R0-3 Management Review
DILG R0-3 IQA Certification
DILG R0-3 Terms of Reference for ISO 9001:2015 Certifying Body (CB) Services
DILG People's Freedom of Information (FOI) Manual
DILG R-3 Official FB Page